Keratin 16 pseudogene 5 (KRT16P5)

Keratin 16 pseudogene 5 (KRT16P5) is classified as a pseudogene related to the keratin gene family, specifically the Keratin 16 gene. Pseudogenes are segments of DNA that are similar to known genes but are nonfunctional; they do not encode active proteins due to disruptive mutations, deletions, or insertions. The keratin gene family encodes intermediate filament proteins that provide structural support to epithelial cells, but pseudogenes like KRT16P5 do not produce functional keratin proteins. KRT16P5 is not considered a therapeutic target or a receptor, enzyme, transporter, or transcription factor. It is classified strictly as a pseudogene and does not encode a functional product. As such, there are no known drugs, mechanisms, or clinical biomarkers associated with it. If you are interested in the functional protein Keratin 16, the correct gene is KRT16 (Keratin 16), which is a protein-coding gene involved in epithelial integrity and certain skin diseases, and not KRT16P5, which is a pseudogene. The only plausible role for a pseudogene like KRT16P5 in biology would be in gene regulation or as a marker in genomic studies, but there is currently no substantial evidence for clinical or therapeutic relevance. There is no information linking KRT16P5 to known drugs, therapeutic mechanisms, or safety concerns. The entity described (KRT16P5) is a pseudogene and not a protein, receptor, enzyme, transporter, or any active therapeutic target. It should not be used as a canonical target for pharmacological or biological intervention.

Other names

Keratin pseudogene KRT16P5KRT16 pseudogene 5KRT16P5